Grifols reported EUR536.1M in EBITDA for its fiscal quarter ending in December of 2024.


Ebitda Change Date
Alaunos Therapeutics USD 16.01M 17.16M Oct/2024
GlaxoSmithKline GBP 3.18B 45M Jun/2025
Grifols EUR 536.1M 71.58M Dec/2024
Life Technologies USD -259000 15.39M Jun/2025